Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Plans Doubling of Respiratory Revenue to $2 Billion
Teva Plans Doubling of Respiratory Revenue to $2 Billion
Teva Plans Doubling of Respiratory Revenue to $2 Billion
Submitted by
admin
on October 9, 2013 - 11:35am
Source:
Bloomberg
News Tags:
Teva
Spiromax
respiratory health
Headline:
Teva Plans Doubling of Respiratory Revenue to $2 Billion
Do Not Allow Advertisers to Use My Personal information
